Condition

Transthyretin Cardiac Amyloidosis clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Transthyretin Cardiac Amyloidosis clinical trials that are recruiting, at sites in 5 countries (most in United States (2), France (2), Germany (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Transthyretin Cardiac Amyloidosis clinical trials

StudyPhaseWhereStatusRegistered
68Ga-FAPI-46 PET imaging to stage ATTR-CM and spot progression Phase 2 Nantes Recruiting Apr 24, 2026
AI-powered ECG tool to detect transthyretin cardiac amyloidosis early. — Evanston, Illinois and 7 other locations Recruiting May 18, 2025
Personalized exercise program for patients with transthyretin cardiac amyloidosis — Boston, Massachusetts Recruiting Apr 4, 2023

All recruiting trials (3)

Related topics

Amyloid Cardiomyopathy

Quick answers

How many Transthyretin Cardiac Amyloidosis clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (2 trials), France (2 trials), Germany (1 trial), Spain (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.